메뉴 건너뛰기




Volumn 125, Issue 5, 2006, Pages 651-653

Diagnostic assays for the JAK2 V617F mutation in chronic myeloproliferative disorders

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; IMATINIB; PROTEIN TYROSINE KINASE;

EID: 33646240825     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/NXXTGRCXD0TMA3C2     Document Type: Editorial
Times cited : (23)

References (12)
  • 1
    • 20144363192 scopus 로고    scopus 로고
    • Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
    • Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365:1054-1061.
    • (2005) Lancet , vol.365 , pp. 1054-1061
    • Baxter, E.J.1    Scott, L.M.2    Campbell, P.J.3
  • 2
    • 20244369569 scopus 로고    scopus 로고
    • Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
    • Levine RL, Wadleigh M, Cools J, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005;7:387-397.
    • (2005) Cancer Cell , vol.7 , pp. 387-397
    • Levine, R.L.1    Wadleigh, M.2    Cools, J.3
  • 3
    • 17844383458 scopus 로고    scopus 로고
    • A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
    • James C, Ugo V, Le Couedic JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005;434:1144-1148.
    • (2005) Nature , vol.434 , pp. 1144-1148
    • James, C.1    Ugo, V.2    Le Couedic, J.P.3
  • 4
    • 17644424955 scopus 로고    scopus 로고
    • A gain-of-function mutation of JAK2 in myeloproliferative disorders
    • Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352:17794790.
    • (2005) N Engl J Med , vol.352 , pp. 17794790
    • Kralovics, R.1    Passamonti, F.2    Buser, A.S.3
  • 5
    • 21344467318 scopus 로고    scopus 로고
    • Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
    • Jones AV, Kreil S, Zoi K, et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood. 2005;106:2162-2168.
    • (2005) Blood , vol.106 , pp. 2162-2168
    • Jones, A.V.1    Kreil, S.2    Zoi, K.3
  • 6
    • 25844447519 scopus 로고    scopus 로고
    • JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia
    • Jelinek J, Oki Y, Gharibyan V, et al. JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia. Blood. 2005;106:3370-3373.
    • (2005) Blood , vol.106 , pp. 3370-3373
    • Jelinek, J.1    Oki, Y.2    Gharibyan, V.3
  • 7
    • 33645545371 scopus 로고    scopus 로고
    • Identification of the JAK2 V617F mutation in chronic myeloproliferative disorders using FRET probes and melting curve analysis
    • Murugesan G, Aboudola S, Szpurka H, et al. Identification of the JAK2 V617F mutation in chronic myeloproliferative disorders using FRET probes and melting curve analysis. Am J Clin Pathol 2006;125:625-633.
    • (2006) Am J Clin Pathol , vol.125 , pp. 625-633
    • Murugesan, G.1    Aboudola, S.2    Szpurka, H.3
  • 8
    • 20744460045 scopus 로고    scopus 로고
    • Identification of an acquired JAK2 mutation in polycythemia vera
    • Zhao R, Xing S, Li Z, et al. Identification of an acquired JAK2 mutation in polycythemia vera. J Biol Chem. 2005;280:22788-22792.
    • (2005) J Biol Chem , vol.280 , pp. 22788-22792
    • Zhao, R.1    Xing, S.2    Li, Z.3
  • 9
    • 33644969827 scopus 로고    scopus 로고
    • Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders
    • McClure R, Mai M, Lasho T. Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders. Leukemia. 2006;20:168-171.
    • (2006) Leukemia , vol.20 , pp. 168-171
    • McClure, R.1    Mai, M.2    Lasho, T.3
  • 10
    • 31444439623 scopus 로고    scopus 로고
    • Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis
    • James C, Delhommeau F, Marzac C, et al. Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis. Leukemia. 2006;20:350-353.
    • (2006) Leukemia , vol.20 , pp. 350-353
    • James, C.1    Delhommeau, F.2    Marzac, C.3
  • 12
    • 33645316081 scopus 로고    scopus 로고
    • Mutation screening for JAK2(V617F): When to order the test and how to interpret the results
    • E pub. PMID# 16460800
    • Tefferi A, Pardanani A. Mutation screening for JAK2(V617F): When to order the test and how to interpret the results. Leuk Res. 2006. E pub. PMID# 16460800.
    • (2006) Leuk Res
    • Tefferi, A.1    Pardanani, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.